Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Verschueren

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase I-II study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinomaH A Sinnige, A G Nanninga, R C Verschueren, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancerE G De Vries, A G Nanninga, J Greidanus, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1993
Recent developments in diagnosis and treatment of metastatic carcinoid tumoursE G De Vries, I P Kema, M J Slooff, et al.
European Journal of Clinical Investigation|July 1, 1997
Effects of hemicolectomy on bile acid metabolism in relation to colon carcinogenesis in manB A van Gorkom, A Cats, R van der Meer, et al.
Cancer|March 1, 1995
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission durationJ Buter, H A Sinnige, D T Sleijfer, et al.
Cancer Research|July 1, 1992
Changes in rectal epithelial cell proliferation and intestinal bile acids after subtotal colectomy in familial adenomatous polyposisA Cats, J H Kleibeuker, F Kuipers, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorinH A Sinnige, J Buter, E G de Vries, et al.
Human Pathology|January 11, 2001
Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation?M J Berends, A Cats, H Hollema, et al.
British Journal of Cancer|November 1, 1992
Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markersB Biesma, P H Willemse, N H Mulder, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase I-II study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinomaH A Sinnige, A G Nanninga, R C Verschueren, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancerE G De Vries, A G Nanninga, J Greidanus, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1993
Recent developments in diagnosis and treatment of metastatic carcinoid tumoursE G De Vries, I P Kema, M J Slooff, et al.
European Journal of Clinical Investigation|July 1, 1997
Effects of hemicolectomy on bile acid metabolism in relation to colon carcinogenesis in manB A van Gorkom, A Cats, R van der Meer, et al.
Cancer|March 1, 1995
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission durationJ Buter, H A Sinnige, D T Sleijfer, et al.
Cancer Research|July 1, 1992
Changes in rectal epithelial cell proliferation and intestinal bile acids after subtotal colectomy in familial adenomatous polyposisA Cats, J H Kleibeuker, F Kuipers, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorinH A Sinnige, J Buter, E G de Vries, et al.
Human Pathology|January 11, 2001
Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation?M J Berends, A Cats, H Hollema, et al.
British Journal of Cancer|November 1, 1992
Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markersB Biesma, P H Willemse, N H Mulder, et al.
Pageof 4